iol Sosud
Khir 2007;13:47-55.
117. Mazzaccaro D, Muzzarelli L, Modafferi A, Righini PC, Settembrini AM,
Nano G. Use of venoactive drugs after surgery for varicose veins: a
preliminary study. Int Angiol 2018;37:79-84.
118. Saveljev VS, Pokrovsky AV, Kirienko AI. Stripping of the great
saphenous vein under micronized puriﬁed ﬂavonoid fraction
(MPFF) protection (results of the Russian multicenter controlled trial
DEFANCE). Phlebolymphology 2008;15:45-51.

Journal of Vascular Surgery: Venous and Lymphatic Disorders

Gloviczki et al

61

Volume 12, Number 1
119. Perrin M, Ramelet AA. Pharmacological treatment of primary
chronic venous disease: rationale, results and unanswered questions. Eur J Vasc Endovasc Surg 2011;41:117-25.
120. Boyle P, Diehm C, Robertson C. Meta-analysis of clinical trials of
Cyclo 3 Fort in the treatment of chronic venous insufﬁciency. Int
Angiol 2003;22:250-62.
121. Cappelli R, Nicora M, Di Perri T. Use of extract of Ruscus aculeatus in
venous disease in the lower limbs. Drugs Exp Clin Res 1988;14:
277-83.
122. Perrins S, Cha A, Qaqish R, Plummer D, Hsu R, Dietzek AM. Clinical
and anatomic outcomes of endovenous radiofrequency ablation
performed on symptomatic small-diameter great saphenous veins.
J Vasc Surg Venous Lymphat Disord 2013;1:245-9.
123. Bendix SD, Peterson EL, Kabbani LS, Weaver MR, Lin JC. Effect of
endovenous ab